| pubmed-article:15517589 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15517589 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:15517589 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:15517589 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:15517589 | lifeskim:mentions | umls-concept:C0278678 | lld:lifeskim |
| pubmed-article:15517589 | lifeskim:mentions | umls-concept:C0879590 | lld:lifeskim |
| pubmed-article:15517589 | lifeskim:mentions | umls-concept:C0524527 | lld:lifeskim |
| pubmed-article:15517589 | lifeskim:mentions | umls-concept:C0051710 | lld:lifeskim |
| pubmed-article:15517589 | lifeskim:mentions | umls-concept:C1517564 | lld:lifeskim |
| pubmed-article:15517589 | lifeskim:mentions | umls-concept:C0300254 | lld:lifeskim |
| pubmed-article:15517589 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:15517589 | pubmed:dateCreated | 2004-11-24 | lld:pubmed |
| pubmed-article:15517589 | pubmed:abstractText | Leuvectin (Vical Inc., San Diego, CA) is a gene transfer product in which a plasmid encoding the human interleukin-2 (IL-2) gene is complexed with the cationic lipid 1,2-dimyristyloxypropyl-3-dimethylhydroxyethyl ammonium bromide/dioleoylphosphatidylethanolamine (DMRIE/DOPE). In the current study, the authors investigated the safety and efficacy of in situ vaccination with Leuvectin in patients with metastatic renal cell carcinoma. | lld:pubmed |
| pubmed-article:15517589 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15517589 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15517589 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15517589 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:15517589 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15517589 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15517589 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15517589 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15517589 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15517589 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15517589 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15517589 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15517589 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:15517589 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:15517589 | pubmed:author | pubmed-author:PeethambaramP... | lld:pubmed |
| pubmed-article:15517589 | pubmed:author | pubmed-author:GalanisEvanth... | lld:pubmed |
| pubmed-article:15517589 | pubmed:author | pubmed-author:RubinJosephJ | lld:pubmed |
| pubmed-article:15517589 | pubmed:author | pubmed-author:PitotHenry... | lld:pubmed |
| pubmed-article:15517589 | pubmed:author | pubmed-author:KaurJudith... | lld:pubmed |
| pubmed-article:15517589 | pubmed:author | pubmed-author:OkunoScott... | lld:pubmed |
| pubmed-article:15517589 | pubmed:author | pubmed-author:FrytakStephen... | lld:pubmed |
| pubmed-article:15517589 | pubmed:author | pubmed-author:SpierCatherin... | lld:pubmed |
| pubmed-article:15517589 | pubmed:author | pubmed-author:UnniKrishnan... | lld:pubmed |
| pubmed-article:15517589 | pubmed:author | pubmed-author:BurchPatrick... | lld:pubmed |
| pubmed-article:15517589 | pubmed:author | pubmed-author:AkporiayeEmma... | lld:pubmed |
| pubmed-article:15517589 | pubmed:author | pubmed-author:LewisBradleyB | lld:pubmed |
| pubmed-article:15517589 | pubmed:author | pubmed-author:RichardsonRon... | lld:pubmed |
| pubmed-article:15517589 | pubmed:copyrightInfo | (c) 2004 American Cancer Society | lld:pubmed |
| pubmed-article:15517589 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15517589 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:15517589 | pubmed:volume | 101 | lld:pubmed |
| pubmed-article:15517589 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15517589 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15517589 | pubmed:pagination | 2557-66 | lld:pubmed |
| pubmed-article:15517589 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:15517589 | pubmed:meshHeading | pubmed-meshheading:15517589... | lld:pubmed |
| pubmed-article:15517589 | pubmed:meshHeading | pubmed-meshheading:15517589... | lld:pubmed |
| pubmed-article:15517589 | pubmed:meshHeading | pubmed-meshheading:15517589... | lld:pubmed |
| pubmed-article:15517589 | pubmed:meshHeading | pubmed-meshheading:15517589... | lld:pubmed |
| pubmed-article:15517589 | pubmed:meshHeading | pubmed-meshheading:15517589... | lld:pubmed |
| pubmed-article:15517589 | pubmed:meshHeading | pubmed-meshheading:15517589... | lld:pubmed |
| pubmed-article:15517589 | pubmed:meshHeading | pubmed-meshheading:15517589... | lld:pubmed |
| pubmed-article:15517589 | pubmed:meshHeading | pubmed-meshheading:15517589... | lld:pubmed |
| pubmed-article:15517589 | pubmed:meshHeading | pubmed-meshheading:15517589... | lld:pubmed |
| pubmed-article:15517589 | pubmed:meshHeading | pubmed-meshheading:15517589... | lld:pubmed |
| pubmed-article:15517589 | pubmed:meshHeading | pubmed-meshheading:15517589... | lld:pubmed |
| pubmed-article:15517589 | pubmed:meshHeading | pubmed-meshheading:15517589... | lld:pubmed |
| pubmed-article:15517589 | pubmed:meshHeading | pubmed-meshheading:15517589... | lld:pubmed |
| pubmed-article:15517589 | pubmed:meshHeading | pubmed-meshheading:15517589... | lld:pubmed |
| pubmed-article:15517589 | pubmed:meshHeading | pubmed-meshheading:15517589... | lld:pubmed |
| pubmed-article:15517589 | pubmed:meshHeading | pubmed-meshheading:15517589... | lld:pubmed |
| pubmed-article:15517589 | pubmed:meshHeading | pubmed-meshheading:15517589... | lld:pubmed |
| pubmed-article:15517589 | pubmed:meshHeading | pubmed-meshheading:15517589... | lld:pubmed |
| pubmed-article:15517589 | pubmed:meshHeading | pubmed-meshheading:15517589... | lld:pubmed |
| pubmed-article:15517589 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15517589 | pubmed:articleTitle | Intratumoral administration of a 1,2-dimyristyloxypropyl-3- dimethylhydroxyethyl ammonium bromide/dioleoylphosphatidylethanolamine formulation of the human interleukin-2 gene in the treatment of metastatic renal cell carcinoma. | lld:pubmed |
| pubmed-article:15517589 | pubmed:affiliation | Department of Oncology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA. galanis.evanthia@mayo.edu | lld:pubmed |
| pubmed-article:15517589 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15517589 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15517589 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:15517589 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| pubmed-article:15517589 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15517589 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15517589 | lld:pubmed |
